1. A novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma. (19th August 2022) Authors: Fan, Wenhua; Wang, Di; Li, Guanzhang; Xu, Jianbao; Ren, Changyuan; Sun, Zhiyan; Wang, Zhiliang; Ma, Wenping; Zhao, Zheng; Bao, Zhaoshi; Jiang, Tao; Zhang, Ying Journal: CNS neuroscience & therapeutics Issue: Volume 28:Number 12(2022) Page Start: 2090 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CGCG clinical practice guidelines for the management of adult diffuse gliomas. Issue 2 (1st June 2016) Authors: Jiang, Tao; Mao, Ying; Ma, Wenbin; Mao, Qing; You, Yongping; Yang, Xuejun; Jiang, Chuanlu; Kang, Chunsheng; Li, Xuejun; Chen, Ling; Qiu, Xiaoguang; Wang, Weimin; Li, Wenbin; Yao, Yu; Li, Shaowu; Li, Shouwei; Wu, Anhua; Sai, Ke; Bai, Hongmin; Li, Guilin Journal: Cancer letters Issue: Volume 375:Issue 2(2016) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation WHO grade II/III gliomas: A prospective randomized study. (February 2022) Authors: Qiu, Xiaoguang; Chen, Yidong; Bao, Zhaoshi; Chen, Li; Jiang, Tao Journal: Radiotherapy and oncology Issue: Volume 167(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical practice guidelines for the management of adult diffuse gliomas. (28th February 2021) Authors: Jiang, Tao; Nam, Do-Hyun; Ram, Zvi; Poon, Wai-sang; Wang, Jiguang; Boldbaatar, Damdindorj; Mao, Ying; Ma, Wenbin; Mao, Qing; You, Yongping; Jiang, Chuanlu; Yang, Xuejun; Kang, Chunsheng; Qiu, Xiaoguang; Li, Wenbin; Li, Shaowu; Chen, Ling; Li, Xuejun; Liu, Zhixiong; Wang, Weimin Journal: Cancer letters Issue: Volume 499(2021) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dexmedetomidine administration during brain tumour resection for prevention of postoperative delirium: a randomised trial. (February 2023) Authors: Li, Shu; Li, Ruowen; Li, Muhan; Cui, Qianyu; Zhang, Xingyue; Ma, Tingting; Wang, Dexiang; Zeng, Min; Li, Hao; Bao, Zhaoshi; Peng, Yuming; Sessler, Daniel I. Journal: British journal of anaesthesia Issue: Volume 130:Number 2(2023) Page Start: e307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma. (26th March 2022) Authors: Ma, Wenping; Bao, Zhaoshi; Qian, Zenghui; Zhang, Kenan; Fan, Wenhua; Xu, Jianbao; Ren, Changyuan; Zhang, Ying; Jiang, Tao Journal: CNS neuroscience & therapeutics Issue: Volume 28:Number 6(2022) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Molecular and clinical characterization of TIM-3 in glioma through 1, 024 samples. (3rd August 2017) Authors: Li, Guanzhang; Wang, Zheng; Zhang, Chuanbao; Liu, Xing; Cai, Jinquan; Wang, Zhiliang; Hu, Huimin; Wu, Fan; Bao, Zhaoshi; Liu, Yanwei; Zhao, Liang; Liang, Tingyu; Yang, Fan; Huang, Ruoyu; Zhang, Wei; Jiang, Tao Journal: Oncoimmunology Issue: Volume 6:Number 8(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Whole‐genome microRNA expression profiling identifies a 5‐microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme. Issue 4 (18th September 2012) Authors: Zhang, Wei; Zhang, Jing; Yan, Wei; You, Gan; Bao, Zhaoshi; Li, Shouwei; Kang, Chunsheng; Jiang, Chuanlu; You, Yongping; Zhang, Yuxiang; Chen, Clark C.; Song, Sonya Wei; Jiang, Tao Journal: Cancer Issue: Volume 119:Issue 4(2013) Page Start: 814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗